ROSSI, MASSIMO
ROSSI, MASSIMO
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Machine Learning Predictive Model to Guide Treatment Allocation for Recurrent Hepatocellular Carcinoma After Surgery
2023 Famularo, S; Donadon, M; Cipriani, F; Fazio, F; Ardito, F; Iaria, M; Perri, P; Conci, S; Dominioni, T; Lai, Q; La Barba, G; Patauner, S; Molfino, S; Germani, P; Zimmitti, G; Pinotti, E; Zanello, M; Fumagalli, L; Ferrari, C; Romano, M; Delvecchio, A; Valsecchi, M; Antonucci, A; Piscaglia, F; Farinati, F; Kawaguchi, Y; Hasegawa, K; Memeo, R; Zanus, G; Griseri, G; Chiarelli, M; Jovine, E; Zago, M; Abu Hilal, M; Tarchi, P; Baiocchi, G; Frena, A; Ercolani, G; Rossi, M; Maestri, M; Ruzzenente, A; Grazi, G; Dalla Valle, R; Romano, F; Giuliante, F; Ferrero, A; Aldrighetti, L; Bernasconi, D; Torzilli, G
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
2009 Mazzaferro, V; Llovet, J; Miceli, R; Bhoori, S; Schiavo, M; Mariani, L; Camerini, T; Roayaie, S; Schwartz, M; Grazi, G; Adam, R; Neuhaus, P; Salizzoni, M; Bruix, J; Forner, A; De Carlis, L; Cillo, U; Burroughs, A; Troisi, R; Rossi, M; Gerunda, G; Lerut, J; Belghiti, J; Boin, I; Gugenheim, J; Rochling, F; Van Hoek, B; Majno, P; Colledan, M; Fagiuoli, S
Double-blind comparison of hepatitis C histological recurrence rate in HCV+ Liver Transplant Recipients Given Basiliximab+Steroids or Basiliximab+Placebo, in addition to Cyclosporine and Azathioprine
2004 Filipponi, F; Callea, F; Salizzoni, M; Grazi, G; Fassati, L; Rossi, M; Risaliti, A; Burra, P; Agnes, S; De Carlis, L; Valente, U; Ferrara, R; Pisati, R